Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia‐Reperfusion Injury
Fundamental & Clinical Pharmacology · 2026-07 · 40 (4)
DOI: 10.1111/fcp.70102 ↗At a glance
Journal article in Fundamental & Clinical Pharmacology, published online on 2026-06-27. Written by Şahhan Kılıç and 12 co-authors. Institution: Department of Cardiology, Ministry of Health Çorlu State Hospital, Çorlu, Tekirdağ, Türkiye. Major MEDLINE topics: Colchicine, Hyperbaric Oxygenation, Myocardial Reperfusion Injury, Cardiotonic Agents. 24 references.
Abstract (original language)
Purpose
Lower extremity ischemia‐reperfusion injury (IRI) triggers systemic inflammation and oxidative stress, causing myocardial remote ischemia‐reperfusion injury (MIRI). Current treatments are limited.
Methods
Male Sprague‐Dawley rats ( n = 6 per group) were assigned to Sham, I/R, I/R + colchicine (C), I/R + HBOT, and I/R + HBOT + C. IRI was induced by 60‐min infrarenal aortic clamping and 120‐h reperfusion. Treatment Once daily colchicine (0.3 mg/kg) and HBOT (2.5 ATA, 100% O 2 ) twice daily were administered for 5 days post‐reperfusion. Cardiac damage, oxidative stress, inflammation, and NRF‐2/HO‐1 signaling were measured, and electrocardiography (ECG) was performed.
Results
I/R caused severe MIRI (Hs‐Troponin T: 568.54 pg/mL; heart OSI: 20.98; TNF‐α: 582.89 pg/mL). Both monotherapies reduced damage, but HBOT + C was superior: Hs‐Troponin T 342.07 pg/mL, OSI 2.26, TNF‐α 278.82 pg/mL, and IL‐6 12.25 pg/mL, with the upper end of the interquartile range for NRF‐2 (41.03) and HO‐1 (14.45) activation and restored redox balance (%DIS/NT: 26.31). No differences were observed between groups on the ECG.
Conclusions
Colchicine suppresses inflammation, relieving inhibition of antioxidant defenses, enabling HBOT to fully activate NRF‐2/HO‐1. This synergistic HBOT + C strategy effectively mitigates MIRI, offering a promising multimodal therapy for remote organ protection after major ischemia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, Ministry of Health Çorlu State Hospital, Çorlu, Tekirdağ, Türkiye.
- Department of Cardiology, Health Sciences University Sultan 2. Abdülhamid Han Training and Research Hospital, Üsküdar, İstanbul, Türkiye.
- Veterinary Clinic, Health Sciences University Hamidiye Experimental Animals Laboratory, İstanbul, Türkiye.
- Department of Medical Biochemistry, Health Sciences University Hamidiye Faculty of Medicine, İstanbul, Türkiye.
- Department of Underwater and Hyperbaric Medicine, Health Sciences University Sultan 2. Abdülhamid Han Training and Research Hospital, Üsküdar, İstanbul, Türkiye.
- Department of Pathology, İstanbul University-Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.
ORCID profiles: Şahhan Kılıç, Süha Asal, Mert Babaoğlu, Cumaali Demirtaş, Samet Yavuz, Eray Metin Güler, Hakan Beyaztaş, Yavuz Aslan, Cansu Türker Sarıçoban, Özge Bengisu Uysal, Mehmet Yıldırım, Mert İlker Hayıroğlu, Tufan Çınar
Cite
APA
Kılıç, Ş., Asal, S., Babaoğlu, M., Demirtaş, C., Yavuz, S., Güler, E. M., Beyaztaş, H., Aslan, Y., Türker Sarıçoban, C., Uysal, Ö. B., Yıldırım, M., Hayıroğlu, M. İ., & Çınar, T. (2026). Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia‐Reperfusion Injury. Fundamental & Clinical Pharmacology, 40(4). https://doi.org/10.1111/fcp.70102
Vancouver
Kılıç Ş, Asal S, Babaoğlu M, Demirtaş C, Yavuz S, Güler EM, et al. Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia‐Reperfusion Injury. Fundamental & Clinical Pharmacology. 2026;40(4). doi:10.1111/fcp.70102
BibTeX
@article{Kl2026,
author = {Kılıç, Şahhan and Asal, Süha and Babaoğlu, Mert and Demirtaş, Cumaali and Yavuz, Samet and Güler, Eray Metin and Beyaztaş, Hakan and Aslan, Yavuz and Türker Sarıçoban, Cansu and Uysal, Özge Bengisu and Yıldırım, Mehmet and Hayıroğlu, Mert İlker and Çınar, Tufan},
title = {Synergistic Cardioprotection of Colchicine and Hyperbaric Oxygen Therapy in a Rat Model of Remote Ischemia‐Reperfusion Injury},
journal = {Fundamental & Clinical Pharmacology},
year = {2026},
volume = {40},
number = {4},
doi = {10.1111/fcp.70102}
}
EUVIMED